质体封装的孕激素有效地抑制了B系细胞的增殖
Toshiro Seki1, Rikio Suzuki2, Shino Ohshima3
1Department of Internal Medicine, Division of Nephrology, Endocrinology, and Metabolism, Tokai University School of Medicine, Isehara, Japan.
Biochemistry and biophysics reports
|April 19, 2024
概括
质体封装的孕 (Lipo-P4) 有效地抑制了B系癌细胞的增殖. 这种新的药物输送系统显示出作为B细胞淋巴瘤和髓瘤的抗癌治疗方法的希望.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 药物输送系统 药物输送系统
背景情况:
- 孕激素通过抑制关键细胞通路来表现出抗癌性质.
- 孕激素的治疗用途受到超生理度的需要的限制.
- 质体封装孕激素 (Lipo-P4) 之前被开发用于增强抗癌疗效.
研究的目的:
- 评估Lipo-P4在抑制B系癌细胞增殖中的有效性.
- 评估Lipo-P4对各种B细胞淋巴瘤和髓瘤细胞系的影响.
- 为了比较Lipo-P4在不同癌症类型中的有效性.
主要方法:
- 选择和分析了六种B细胞淋巴瘤和两种髓瘤细胞系的表面标记物,使用流细胞计.
- 准备的脂质体封装的孕激素 (Lipo-P4).
- 评估了Lipo-P4对B系癌细胞,卵巢清细胞癌,前列腺癌和三阴性乳腺癌细胞系的扩散的影响.
主要成果:
- 在所有测试的癌症细胞系中,Lipo-P4显著抑制了增殖.
- 除了一个例外外,B系癌细胞系对Lipo-P4的敏感性比其他癌症类型更高.
- 空脂质体对癌细胞增殖没有任何抑制作用.
结论:
- 脂质体封装增强了孕激素抑制癌细胞增殖的能力.
- 利波-P4是B系癌细胞增殖的强有力的抑制剂.
- 利波-P4代表了对B系恶性瘤的有希望的抗癌药物候选者.
相关概念视频
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Ovarian Cycle
1.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.2K
Hormonal Control of the Ovarian Cycle
476
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
476


